These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 32123890)

  • 1. Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapy.
    Qin WW; Pan ZY; Cai DH; Li Y; He L
    Dalton Trans; 2020 Mar; 49(11):3562-3569. PubMed ID: 32123890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.
    Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A
    Eur J Med Chem; 2024 Oct; 276():116618. PubMed ID: 38972079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclometalated iridium(III) tetrazine complexes for mitochondria-targeted two-photon photodynamic therapy.
    Tan Z; Lin M; Liu J; Wu H; Chao H
    Dalton Trans; 2024 Aug; 53(31):12917-12926. PubMed ID: 39028267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes.
    Li Y; Wang KN; He L; Ji LN; Mao ZW
    J Inorg Biochem; 2020 Apr; 205():110976. PubMed ID: 31926377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer activity and mechanism studies of photoactivated iridium(III) complexes toward lung cancer A549 cells.
    Zhou L; Li J; Chen J; Yao X; Zeng X; Liu Y; Wang Y; Wang X
    Dalton Trans; 2024 Sep; 53(36):15176-15189. PubMed ID: 39221457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
    Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of pH-responsive cyclometalated iridium(III) complex and its application in the selective killing of cancerous cells.
    Yang P; Zhang S; Wang K; Qi H
    Dalton Trans; 2021 Nov; 50(46):17338-17345. PubMed ID: 34788356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards efficient Ir(III) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands.
    Sanz-Villafruela J; Bermejo-Casadesús C; Martínez-Alonso M; Moro A; Lima JC; Massaguer A; Espino G
    Dalton Trans; 2024 Jul; 53(27):11393-11409. PubMed ID: 38899369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-wavelength triggered iridium(III) complex nanoparticles for photodynamic therapy against hypoxic cancer.
    Liu S; Wang Z; Wu Z; Chen H; Zhu D; Li G; Yan M; Bryce MR; Chang Y
    Chem Commun (Camb); 2024 Sep; 60(73):9938-9941. PubMed ID: 39171567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
    Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
    Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
    J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Mitochondria-Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia.
    Lv W; Zhang Z; Zhang KY; Yang H; Liu S; Xu A; Guo S; Zhao Q; Huang W
    Angew Chem Int Ed Engl; 2016 Aug; 55(34):9947-51. PubMed ID: 27381490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the tumor cell selectivity of a rhodamine-decorated iridium(III) complex by conjugating with indomethacin for COX-2 targeted photodynamic therapy.
    Liu C; Xiang J; Xiang C; Li H
    Bioorg Chem; 2021 Sep; 114():105142. PubMed ID: 34243072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
    Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
    Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bombesin-Targeted Delivery of β-Carboline-Based Ir(III) and Ru(II) Photosensitizers for a Selective Photodynamic Therapy of Prostate Cancer.
    Sanz-Villafruela J; Bermejo-Casadesús C; Riesco-Llach G; Iglesias M; Martínez-Alonso M; Planas M; Feliu L; Espino G; Massaguer A
    Inorg Chem; 2024 Oct; 63(41):19140-19155. PubMed ID: 39361042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleus-Targeted Organoiridium-Albumin Conjugate for Photodynamic Cancer Therapy.
    Zhang P; Huang H; Banerjee S; Clarkson GJ; Ge C; Imberti C; Sadler PJ
    Angew Chem Int Ed Engl; 2019 Feb; 58(8):2350-2354. PubMed ID: 30552796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trifluoromethyl-Substituted Iridium(III) Complexes: From Photophysics to Photooxidation of a Biological Target.
    Bevernaegie R; Marcélis L; Laramée-Milette B; De Winter J; Robeyns K; Gerbaux P; Hanan GS; Elias B
    Inorg Chem; 2018 Feb; 57(3):1356-1367. PubMed ID: 29336560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray tomography of cryopreserved human prostate cancer cells: mitochondrial targeting by an organoiridium photosensitiser.
    Bolitho EM; Sanchez-Cano C; Huang H; Hands-Portman I; Spink M; Quinn PD; Harkiolaki M; Sadler PJ
    J Biol Inorg Chem; 2020 Mar; 25(2):295-303. PubMed ID: 32124100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
    McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
    Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
    Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.